Evrópusambandið - íslenska - EMA (European Medicines Agency)

novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - Önnur æxlishemjandi lyf - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.

Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

intervet international b.v.* - emamectin benzoate - forblanda fyrir lyfjablandað fóður - 0,2 %

Evrópusambandið - íslenska - EMA (European Medicines Agency)

novo nordisk a/s - semaglútíð - obesity; overweight - Ónæmiskerfi, þó ekki mataræði - wegovy is indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with an initial body mass index (bmi) of- ≥30 kg/m² (obesity), or- ≥27 kg/m² to.